Advertisement

Topics

Nemaura Medical Announces Proposed Public Offering

20:09 EST 17 Dec 2018 | Biotech 365

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, today announced a proposed registered public offering of its … Continue reading

Original Article: Nemaura Medical Announces Proposed Public Offering

NEXT ARTICLE

More From BioPortfolio on "Nemaura Medical Announces Proposed Public Offering"

Advertisement
Quick Search
Advertisement
Advertisement